Summary | Improved Antibodies Against ERBB4/HER4

Crowdsourcing scientists around the world with orphan and dormant intellectual property (IP).

Join Us Sign In

This is the pilot version of Therapoid. Register or Sign in as a pilot user to collaborate.

Provided by: National Institutes of Health (NIH)
Tags:

Short Description:

This technology pertains to specific rabbit monoclonal antibodies generated against the ErbB4 receptor (also known as HER4) that have been validated for specificity using tissue sections and extracts from ErbB4 knockout mice.

Projects based on this Technology

Start New Project